Segment Disclosures - Schedule of Information for the Reportable Segments (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
Jun. 30, 2025	Jun. 30, 2024	Mar. 31, 2024	Jun. 30, 2025	Jun. 30, 2024
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Total revenues	$ 694,348	$ 695,504		$ 1,397,237	$ 1,302,064
Plus: Adjustments to NOI	24,144	25,458		51,063	53,019
Interest income and other	15,806	7,832		31,627	13,583
Interest expense	(75,063)	(74,910)		(147,756)	(135,817)
Depreciation and amortization	(265,916)	(283,498)		(534,462)	(502,717)
General and administrative	(20,764)	(26,718)		(46,882)	(50,017)
Transaction and merger-related costs	(10,215)	(7,759)		(15,749)	(114,979)
Impairments and loan loss reserves, net	(3,499)	553		63	(10,905)
Gain (loss) on sales of real estate, net	1,636	122,044		1,636	125,299
Other income (expense), net	(4,692)	4,004		(10,818)	82,520
Less: Healthpeak’s share of unconsolidated joint venture Adjusted NOI	(9,948)	(7,212)		(15,347)	(12,405)
Plus: Noncontrolling interests’ share of consolidated joint venture Adjusted NOI	7,219	6,756		14,413	13,322
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures	39,654	155,393		93,945	177,892
Outpatient Medical
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Gain (loss) on sales of real estate, net		122,000	$ 3,000
Operating Segment
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Total revenues	678,542	687,672		1,365,610	1,288,481
Healthpeak’s share of unconsolidated joint venture total revenues	14,541	11,204		24,600	18,804
Noncontrolling interests’ share of consolidated joint venture total revenues	(10,020)	(9,374)		(19,993)	(18,413)
Operating expenses	(276,181)	(273,827)		(549,324)	(517,556)
Healthpeak’s share of unconsolidated joint venture operating expenses	(4,593)	(3,992)		(9,253)	(6,399)
Noncontrolling interests’ share of consolidated joint venture operating expenses	2,801	2,618		5,580	5,091
Adjustments to NOI	(24,144)	(25,458)		(51,063)	(53,019)
Adjusted NOI for reportable segments	380,946	388,843		766,157	716,989
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures	39,654	155,393		93,945	177,892
Operating Segment \| Outpatient Medical
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Total revenues	320,482	332,515		641,030	570,787
Healthpeak’s share of unconsolidated joint venture total revenues	7,183	6,903		14,442	9,642
Noncontrolling interests’ share of consolidated joint venture total revenues	(10,020)	(9,341)		(19,993)	(18,217)
Operating expenses	(105,331)	(111,702)		(210,557)	(192,970)
Healthpeak’s share of unconsolidated joint venture operating expenses	(2,695)	(2,464)		(5,689)	(3,547)
Noncontrolling interests’ share of consolidated joint venture operating expenses	2,801	2,609		5,580	5,039
Adjustments to NOI	(10,813)	(10,430)		(22,895)	(16,556)
Adjusted NOI for reportable segments	201,607	208,090		401,918	354,178
Operating Segment \| Lab
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Total revenues	209,205	214,266		426,798	438,027
Healthpeak’s share of unconsolidated joint venture total revenues	7,358	4,301		10,158	9,162
Noncontrolling interests’ share of consolidated joint venture total revenues	0	(33)		0	(196)
Operating expenses	(59,401)	(56,656)		(117,059)	(113,496)
Healthpeak’s share of unconsolidated joint venture operating expenses	(1,898)	(1,528)		(3,564)	(2,852)
Noncontrolling interests’ share of consolidated joint venture operating expenses	0	9		0	52
Adjustments to NOI	(12,488)	(13,289)		(27,325)	(34,724)
Adjusted NOI for reportable segments	142,776	147,070		289,008	295,973
Operating Segment \| CCRC
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Total revenues	148,855	140,891		297,782	279,667
Healthpeak’s share of unconsolidated joint venture total revenues	0	0		0	0
Noncontrolling interests’ share of consolidated joint venture total revenues	0	0		0	0
Operating expenses	(111,449)	(105,469)		(221,708)	(211,090)
Healthpeak’s share of unconsolidated joint venture operating expenses	0	0		0	0
Noncontrolling interests’ share of consolidated joint venture operating expenses	0	0		0	0
Adjustments to NOI	(843)	(1,739)		(843)	(1,739)
Adjusted NOI for reportable segments	$ 36,563	$ 33,683		$ 75,231	$ 66,838

Adjusted NOI is a non-GAAP supplemental financial measure used to evaluate the operating performance of real estate. Adjusted NOI is calculated as NOI after eliminating the effects of straight-line rents, DFL non-cash interest, amortization of market lease intangibles and lease termination fees (?non cash adjustments?). Adjusted NOI is oftentimes referred to as ?cash NOI.? The Company uses adjusted NOI to make decisions about resource allocations, and to assess and compare property level performance. The Company believes that net income (loss) is the most directly comparable U.S. GAAP measure to adjusted NOI. Adjusted NOI should not be viewed as an alternative measure of operating performance to net income (loss) as defined by GAAP since it does not reflect various excluded items. Further, the Company?s definition of Adjusted NOI may not be comparable to the definition used by other REITs or real estate companies, as they may use different methodologies for calculating Adjusted NOI.

No definition available.